Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

July 31, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

September 1, 2023

Conditions

Dry Age-related Macular DegenerationGeographic AtrophyGene TherapyIntravitreal Injection

Interventions

BIOLOGICAL

Intravitreal AAVCAGsCD59

AAVCAGsCD59 is administered as an intravitreal injection in the enrolled eye

OTHER

Intravitreal Sham Injection

Sham injection mimics a real injection in the enrolled eye